Locations:
Search IconSearch
August 7, 2020/Cancer/News & Insight

Did He Know He Was Dying?

Reflections on treating a patient with cognitive differences

650×450-Cleveland-Clinic-Cancer

The patient was unable to accept blood transfusions, and his cognitive differences prevented him from understanding the course of his leukemia as it progressed. Mikkael Sekeres, MD, MS, writes about what it was like to care for a patient with a loving family, limited treatment options and cognitive differences in the solitary times of COVID-19 in this New York Times column.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

“At the end, he didn’t suffer much. And as a parent, I can’t say for certain that I would have the strength to care for a dying child at home,” Dr. Sekeres writes. “But I also can’t be certain if it was right to preserve his hope until he passed, while leaving him unprepared for a solitary death; perhaps unaware of what was occurring, but perhaps aware.”

Dr. Sekeres is Director of Cleveland Clinic Cancer Center’s Leukemia Program. You can follow him on Twitter @MikkaelSekeres.

Advertisement

Related Articles

adverse events from immune checkpoint inhibitors
December 21, 2023/Cancer/News & Insight
Managing Hormone Dysfunction-Related Adverse Events of Immunotherapy for Breast Cancer Treatment

Timing and type of side effects differ greatly from chemotherapy

23-CNR-4274330-CQD-Hero-650×450
October 18, 2023/Cancer/News & Insight
Cleveland Clinic Lerner Research Institute to Host Head & Neck Cancer CME Symposium

Sessions explore treatment advances and multidisciplinary care

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/News & Insight
Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

23-CNR-4071967-CQD-Hero-650×450 scan for triple-negative breast cancer case study
September 19, 2023/Cancer/News & Insight
Patient With Stage 4 Triple-Negative Breast Cancer in Remission 10 Years After Initial Diagnosis

Combination of olaparib and carboplatin results in complete durable response for a patient with BRCA2 and “BRCAness” mutations

23-CNR-4140381-CQD-Hero-650×450 eye toxicities in cancer treatment
September 7, 2023/Cancer/News & Insight
Eye Toxicities More Prevalent Side Effect of Cancer Treatment Than Previously Understood

Early communication between oncologists and ophthalmologist warranted

23-CNR-4185077-CQD-Hero-650×450
August 31, 2023/Cancer/News & Insight
CME Program Takes Multidisciplinary Approach to Colorectal Cancer

Case-based course delves into latest treatment approaches

outreach to underserved communities
June 2, 2023/Cancer/News & Insight
Focus Groups Amplify the Voices of Black Congregants about Disparities in Clinical Trials

Long-term relationship building and engagement key to gaining community trust

Ad